Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.

Dieter Hörsch,Lowell Anthony,David J Gross,Juan W Valle,Staffan Welin,Marta Benavent,Martyn Caplin,Marianne Pavel,Emily Bergsland,Kjell Öberg,Kenneth B Kassler-Taub,Polina Binder,Phillip Banks,Pablo Lapuerta,Matthew H Kulke

NEUROENDOCRINOLOGY（2022）

引用 5|浏览8

暂无评分

摘要

Safety results of TELEPATH support the long-term use of telotristat ethyl in patients with CS diarrhea. Telotristat ethyl was well-tolerated and associated with sustained improvement in QOL scores (NCT02026063).

查看译文

关键词

Carcinoid syndrome,Diarrhea,Quality of life,Safety and tolerability,Telotristat ethyl

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要